People with intellectual disabilities (ID) face significant barriers when it comes to participating in population-based cancer screening programs, a recent study published in The Lancet Public Health journal has found. Researchers from Radboudumc and the academic collaborative Intellectual Disability and Health have highlighted the need for tailored support for this vulnerable population.
Individuals with ID are at a higher risk of health issues compared to the general population, making early detection through screening crucial. However, the study revealed that people with ID are much less likely to participate in screenings for cervical, breast, and colon cancer compared to those without ID. Despite similar rates of unfavorable outcomes in both groups, individuals with ID experienced more difficulties during the screening process and follow-up examinations.
The research, which analyzed data from nearly 200,000 people with ID, found that participation rates in population screenings were significantly lower for individuals with ID across all three types of cancer. Moreover, results were more often inconclusive or procedures could not be performed properly in this group. This not only delays diagnosis and treatment but also indicates a lack of consideration for the specific needs of individuals with ID.
Lead author Amina Banda emphasized the importance of adapting population screening to better meet the needs of people with ID. Project leader Dr. Maarten Cuypers stressed the necessity for improved support in decision-making about participation and called for a more inclusive approach to screening implementation.
In response to these findings, the Dutch Association of Intellectual Disability Physicians (NVAVG) is developing a guide to help care providers navigate population screening for individuals with ID. This guide will incorporate insights from the study and aims to enhance participation and decision-making processes in the future.
The RIVM, which coordinates population screening in the Netherlands, has also recognized the need for improved accessibility. Project leader Karin Honig from the Center for Population Screening at RIVM highlighted efforts to provide easily understandable information, such as through Steffie.nl, and expressed support for the NVAVG’s guide to enhance accessibility and decision-making surrounding participation in population screening.
The study’s findings underscore the importance of tailored support for individuals with ID in accessing cancer screening programs. By addressing the specific needs of this population, healthcare providers can help reduce disparities in cancer detection and improve outcomes for individuals with intellectual disabilities.
